The clinical significance of p53 accumulation in gastric carcinoma

作者: Teresa Starzynska , Maciej Markiewski , Wenancjusz Domagala , Krzysztof Marlicz , Janusz Mietkiewski

DOI: 10.1002/(SICI)1097-0142(19960515)77:10<2005::AID-CNCR7>3.0.CO;2-P

关键词:

摘要: BACKGROUND. Alterations in the expression of p53 tumor suppressor protein is a frequent event human cancer but practical implications this phenomenon are yet to be fully exploited. The objective study was determine value accumulation as marker progression and prognosis gastric carcinoma patients evaluate whether parameter can properly assessed prior surgery. METHODS. studied immunohistochemically 200 carcinomas using paraffin embedded surgical specimens endoscopic biopsies. correlation between tissue, selected clinicopathologic variables, course patients' disease were analyzed. RESULTS. Results showed that 42.5% expressed elevated levels protein. P53 positivity correlated with increasing stage size (P < 0.001 P = 0.025, respectively). positive tumors had higher propensity for lymph node distant metastases 0.001). also more frequently detected from proximal rather than distal stomach 0.027). In receiving potentially curative resection advanced cancer, an independent strongest poor (RR 3.7, There complete concordance immunohistochemical detection material. CONCLUSIONS. A preoperative assessment helpful identify at high risk metastatic spread regional nodes independently those especially prognosis. When combined routine procedures, simple inexpensive test might allow appropriate planning better treatment strategies.

参考文章(35)
J Bártková, B Vojtĕsek, J Lukás, J Bártek, D P Lane, C A Midgley, A Rejthar, Z Stasková, J Kovarík, J V Gannon, Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. ,vol. 6, pp. 1699- 1703 ,(1991)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
A. Berchuck, D. L. Clarke-Pearson, Billie-Jo M. Kerns, Andrew M. Davidoff, Robert C. Bast Jr., Jeffrey R. Marks, Jeffrey C. Pence, R. K. Dodge, James Dirk Iglehart, P. A. Humphrey, Overexpression and Mutation of p53 in Epithelial Ovarian Cancer Cancer Research. ,vol. 51, pp. 2979- 2984 ,(1991)
C A Finlay, P W Hinds, T H Tan, D Eliyahu, M Oren, A J Levine, Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Molecular and Cellular Biology. ,vol. 8, pp. 531- 539 ,(1988) , 10.1128/MCB.8.2.531
R. Elledge, S. A. W. Fuqua, R. W. Brown, G. C. Chamness, C. K. Osborne, W. L. McGuire, D. C. Allred, G. M. Clark, Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer Journal of the National Cancer Institute. ,vol. 85, pp. 200- 206 ,(1993) , 10.1093/JNCI/85.3.200
BV Joypaul, D Hopwood, EL Newman, S Qureshi, A Grant, SA Ogston, DP Lane, A Cuschieri, THE PROGNOSTIC SIGNIFICANCE OF THE ACCUMULATION OF P53 TUMOUR-SUPPRESSOR GENE PROTEIN IN GASTRIC ADENOCARCINOMA British Journal of Cancer. ,vol. 69, pp. 943- 946 ,(1994) , 10.1038/BJC.1994.182
Y Remvikos, O Tominaga, P Hammel, P Laurent-Puig, RJ Salmon, B Dutrillaux, G Thomas, Increased p53 protein content of colorectal tumours correlates with poor survival British Journal of Cancer. ,vol. 66, pp. 758- 764 ,(1992) , 10.1038/BJC.1992.352
Y Kakeji, D Korenaga, S Tsujitani, H Baba, H Anai, Y Maehara, K Sugimachi, Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. British Journal of Cancer. ,vol. 67, pp. 589- 593 ,(1993) , 10.1038/BJC.1993.108
D. P. Lane, The regulation of p53 function: Steiner award lecture International Journal of Cancer. ,vol. 57, pp. 623- 627 ,(1994) , 10.1002/IJC.2910570502